サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1458009

医薬品無菌試験の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測

Global Pharmaceutical Sterility Testing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日: | 発行: Value Market Research | ページ情報: 英文 338 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.16円
医薬品無菌試験の世界市場調査レポート：産業分析、規模、シェア、成長、動向、2024年から2032年までの予測
出版日: 2024年03月01日
発行: Value Market Research
ページ情報: 英文 338 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医薬品無菌試験市場の世界需要は、調査期間2024～2032年のCAGR12.03%で、2023年の17億5,000万米ドルから2032年には48億6,000万米ドル近くの市場規模に達すると推定されます。

医薬品の無菌試験は、医薬品や無菌製品に生存可能な微生物が存在しないことを確認する、製薬業界における重要な品質管理プロセスです。この試験により、医薬品が安全性と有効性に関する規制基準を満たしていることが保証されます。無菌試験には、サンプルを適切な培地で培養し、培養して微生物汚染を検出することが含まれます。注射剤や眼科用剤を含む無菌医薬品の完全性を維持し、患者の感染リスクを防止するための重要なステップです。

市場力学

医薬品無菌試験市場は、厳しい規制要件、医薬品数の増加、製品の品質と患者の安全性の重視の高まりにより、大幅な成長を遂げています。無菌試験は、医薬品の安全性と有効性を損なう可能性のある生菌が製品に混入していないことを確認するため、医薬品製造において重要な役割を果たしています。世界中の規制当局は厳格な無菌試験プロトコルを義務付けており、これが高度な試験技術とサービスの需要に寄与しています。製薬業界、特に生物製剤と個別化医療の拡大は、無菌試験の必要性をさらに高めています。さらに、医薬品製造と試験サービスのアウトソーシングが増加していることも、医薬品無菌試験市場の成長を後押ししています。迅速無菌試験を含む革新的な試験方法の継続的開拓は、市場力学を強化します。医薬品無菌試験市場は、規制遵守、業界の成長、医薬品の品質と安全性の絶え間ない追求によって牽引されています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは医薬品無菌試験の世界市場における各セグメントを包括的に評価することもできます。医薬品無菌試験業界の成長と動向は、この研究に全体的なアプローチを提供します。

市場セグメンテーション

医薬品無菌試験市場レポートのこのセクションでは、国と地域レベルのセグメントに関する詳細なデータを提供し、それによって戦略家が今後の機会で、それぞれの製品やサービスの対象層を特定するのに役立ちます。

タイプ別

  • 社内
  • アウトソーシング

製品タイプ別

  • キットと試薬
  • 器具
  • サービス

試験タイプ別

  • 無菌試験（膜濾過、直接接種、製品洗浄）
  • 生物負荷試験
  • 細菌内毒素試験

サンプル別

  • 医薬品
  • 医療機器
  • バイオ医薬品

用途別

  • 調剤薬局
  • 医療機器メーカー
  • 製薬会社
  • その他

地域分析

本セクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカの医薬品無菌試験市場の現在と将来の需要を強調する地域展望をカバーします。さらに、著名な全地域における個々の用途セグメントの需要・推定・予測にも焦点を当てています。

  • 医薬品無菌試験の世界の地域別市場シェア（代表グラフ）
  • 医薬品無菌試験の世界市場シェア

カスタムメイドのご要望がございましたら、弊社までご連絡ください。当社の調査チームは、お客様のニーズに応じてカスタマイズしたレポートを提供することができます。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 医薬品無菌試験-産業分析

  • イントロダクション：市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカー一覧
    • 主要原材料の価格動向
  • 潜在的バイヤー一覧
  • マーケティングチャネル
    • 直接マーケティング
    • 間接マーケティング
    • マーケティングチャネル発展動向

第5章 医薬品無菌試験の世界市場分析：タイプ別

  • タイプ別概要
  • 実績データと予測データ
  • タイプ別分析
  • 社内
  • アウトソーシング

第6章 医薬品無菌試験の世界市場分析：製品タイプ別

  • 製品タイプ別概要
  • 実績データと予測データ
  • 製品タイプ別分析
  • キットと試薬
  • 器具
  • サービス

第7章 医薬品無菌試験の世界市場分析：試験タイプ別

  • 試験タイプ別概要
  • 実績データと予測データ
  • 試験タイプ別分析
  • 無菌試験（膜濾過、直接接種、製品洗浄）
  • 生物負荷試験
  • 細菌エンドトキシン試験

第8章 医薬品無菌試験の世界市場分析：サンプル別

  • サンプル別概要
  • 実績データと予測データ
  • サンプル別分析
  • 医薬品
  • 医療機器
  • バイオ医薬品

第9章 医薬品無菌試験の世界市場分析：最終用途別

  • 最終用途別概要
  • 実績データと予測データ
  • 最終用途別分析
  • 調剤薬局
  • 医療機器企業
  • 製薬会社
  • その他

第10章 医薬品無菌試験の世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第11章 医薬品無菌試験企業の競合情勢

  • 医薬品無菌試験市場の競合
  • 提携・協力・契約
  • 合併・買収
  • 新製品上市
  • その他の開発

第12章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Pacific Biolabs
  • Steris Plc
  • Boston Analytical
  • Nelson Laboratories LLC（Sotera Health）
  • Sartorius AG
  • SOLVIAS AG
  • SGS SA
  • Labcorp
  • Pace Analytical
  • Charles River Laboratories
  • Thermo Fisher Scientific Inc.
  • Rapid Micro Biosystems
  • Almac Group
  • Labor LS SE & Co KG
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis by Type (USD MN)
  • In-House Market Sales by Geography (USD MN)
  • Outsourcing Market Sales by Geography (USD MN)
  • Analysis Market by Product Type (USD MN)
  • Kits And Reagents Market Sales by Geography (USD MN)
  • Instruments Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Analysis by Test Type (USD MN)
  • Sterility Testing (Membrane Filtration, Direct Inoculation, Product Flush) Market Sales by Geography (USD MN)
  • Bioburden Testing Market Sales by Geography (USD MN)
  • Bacterial Endotoxin Testing Market Sales by Geography (USD MN)
  • Analysis by Sample (USD MN)
  • Pharmaceuticals Market Sales by Geography (USD MN)
  • Medical Devices Market Sales by Geography (USD MN)
  • Biopharmaceuticals Market Sales by Geography (USD MN)
  • Analysis by End-use (USD MN)
  • Compounding Pharmacies Market Sales by Geography (USD MN)
  • Medical Device Companies Market Sales by Geography (USD MN)
  • Pharmaceutical Companies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Pharmaceutical Sterility Testing Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Pharmaceutical Sterility Testing Report
  • Market Research Process
  • Market Research Methodology
  • Global Pharmaceutical Sterility Testing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Test Type
  • Market Attractiveness Analysis by Sample
  • Market Attractiveness Analysis by End-use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • In-House Market Sales by Geography (USD MN)
  • Outsourcing Market Sales by Geography (USD MN)
  • Global Market Analysis by Product Type (USD MN)
  • Kits And Reagents Market Sales by Geography (USD MN)
  • Instruments Market Sales by Geography (USD MN)
  • Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Test Type (USD MN)
  • Sterility Testing (Membrane Filtration, Direct Inoculation, Product Flush) Market Sales by Geography (USD MN)
  • Bioburden Testing Market Sales by Geography (USD MN)
  • Bacterial Endotoxin Testing Market Sales by Geography (USD MN)
  • Global Market Analysis by Sample (USD MN)
  • Pharmaceuticals Market Sales by Geography (USD MN)
  • Medical Devices Market Sales by Geography (USD MN)
  • Biopharmaceuticals Market Sales by Geography (USD MN)
  • Global Market Analysis by End-use (USD MN)
  • Compounding Pharmacies Market Sales by Geography (USD MN)
  • Medical Device Companies Market Sales by Geography (USD MN)
  • Pharmaceutical Companies Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112113912

The global demand for Pharmaceutical Sterility Testing Market is presumed to reach the market size of nearly USD 4.86 BN by 2032 from USD 1.75 BN in 2023 with a CAGR of 12.03% under the study period 2024 - 2032.

Pharmaceutical sterility testing is a critical quality control process in the pharmaceutical industry that verifies the absence of viable microorganisms in drugs and sterile products. This testing ensures that pharmaceuticals meet regulatory standards for safety and efficacy. Sterility testing involves culturing samples in suitable media and incubating them to detect microbial contamination. It is a key step in maintaining the integrity of sterile pharmaceuticals, including injectables and ophthalmic products and preventing the risk of patient infections.

MARKET DYNAMICS

The pharmaceutical sterility testing market is witnessing substantial growth driven by stringent regulatory requirements, the rising number of pharmaceutical products, and the increasing emphasis on product quality and patient safety. Sterility testing plays a critical role in pharmaceutical manufacturing to ensure that products are free from viable microorganisms that could compromise their safety and efficacy. Regulatory authorities worldwide mandate rigorous sterility testing protocols, contributing to the demand for advanced testing technologies and services. Expanding the pharmaceutical industry, especially in biologics and personalized medicine, further boosts the need for sterility testing. Additionally, the increasing outsourcing of pharmaceutical manufacturing and testing services fuels pharmaceutical sterility testing market growth. The continuous development of innovative testing methods, including rapid sterility testing, enhances market dynamics. The pharmaceutical sterility testing market is driven by regulatory compliance, industry growth, and the relentless pursuit of pharmaceutical quality and safety.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pharmaceutical sterility testing. The growth and trends of pharmaceutical sterility testing industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the pharmaceutical sterility testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • In-House
  • Outsourcing

By Product Type

  • Kits And Reagents
  • Instruments
  • Services

By Test Type

  • Sterility Testing (Membrane Filtration, Direct Inoculation, Product Flush)
  • Bioburden Testing
  • Bacterial Endotoxin Testing

By Sample

  • Pharmaceuticals
  • Medical Devices
  • Biopharmaceuticals

By End-Use

  • Compounding Pharmacies
  • Medical Device Companies
  • Pharmaceutical Companies
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pharmaceutical Sterility Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

  • GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
  • Global Pharmaceutical Sterility Testing Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pharmaceutical Sterility Testing market include Pacific Biolabs, Steris Plc, Boston Analytical, Nelson Laboratories, LLC (Sotera Health), Sartorius AG, SOLVIAS AG, SGS SA, Labcorp, Pace Analytical, Charles River Laboratories, Thermo Fisher Scientific, Inc., Rapid Micro Biosystems, Almac Group,Labor LS SE & Co, KG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PHARMACEUTICAL STERILITY TESTING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Product Type
    • 3.7.3 Market Attractiveness Analysis By Test Type
    • 3.7.4 Market Attractiveness Analysis By Sample
    • 3.7.5 Market Attractiveness Analysis By End-use
    • 3.7.6 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 In-House Historic and Forecast Sales by Regions
  • 5.5 Outsourcing Historic and Forecast Sales by Regions

6 . GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Kits And Reagents Historic and Forecast Sales by Regions
  • 6.5 Instruments Historic and Forecast Sales by Regions
  • 6.6 Services Historic and Forecast Sales by Regions

7 . GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET ANALYSIS BY TEST TYPE

  • 7.1 Overview by Test Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Test Type
  • 7.4 Sterility Testing (Membrane Filtration, Direct Inoculation, Product Flush) Historic and Forecast Sales by Regions
  • 7.5 Bioburden Testing Historic and Forecast Sales by Regions
  • 7.6 Bacterial Endotoxin Testing Historic and Forecast Sales by Regions

8 . GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET ANALYSIS BY SAMPLE

  • 8.1 Overview by Sample
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Sample
  • 8.4 Pharmaceuticals Historic and Forecast Sales by Regions
  • 8.5 Medical Devices Historic and Forecast Sales by Regions
  • 8.6 Biopharmaceuticals Historic and Forecast Sales by Regions

9 . GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET ANALYSIS BY END-USE

  • 9.1 Overview by End-use
  • 9.2 Historical and Forecast Data
  • 9.3 Analysis by End-use
  • 9.4 Compounding Pharmacies Historic and Forecast Sales by Regions
  • 9.5 Medical Device Companies Historic and Forecast Sales by Regions
  • 9.6 Pharmaceutical Companies Historic and Forecast Sales by Regions
  • 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL PHARMACEUTICAL STERILITY TESTING MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2. North America By Segment Sales Analysis
    • 10.3.3. North America By Country Sales Analysis
    • 10.3.4. United State Sales Analysis
    • 10.3.5. Canada Sales Analysis
    • 10.3.6. Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2. Europe by Segment Sales Analysis
    • 10.4.3. Europe by Country Sales Analysis
    • 10.4.4. United Kingdom Sales Analysis
    • 10.4.5. France Sales Analysis
    • 10.4.6. Germany Sales Analysis
    • 10.4.7. Italy Sales Analysis
    • 10.4.8. Russia Sales Analysis
    • 10.4.9. Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2. Asia Pacific by Segment Sales Analysis
    • 10.5.3. Asia Pacific by Country Sales Analysis
    • 10.5.4. China Sales Analysis
    • 10.5.5. India Sales Analysis
    • 10.5.6. Japan Sales Analysis
    • 10.5.7. South Korea Sales Analysis
    • 10.5.8. Australia Sales Analysis
    • 10.5.9. South East Asia Sales Analysis
    • 10.5.10. Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2. Latin America by Segment Sales Analysis
    • 10.6.3. Latin America by Country Sales Analysis
    • 10.6.4. Brazil Sales Analysis
    • 10.6.5. Argentina Sales Analysis
    • 10.6.6. Peru Sales Analysis
    • 10.6.7. Chile Sales Analysis
    • 10.6.8. Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2. Middle East & Africa by Segment Sales Analysis
    • 10.7.3. Middle East & Africa by Country Sales Analysis
    • 10.7.4. Saudi Arabia Sales Analysis
    • 10.7.5. UAE Sales Analysis
    • 10.7.6. Israel Sales Analysis
    • 10.7.7. South Africa Sales Analysis
    • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE PHARMACEUTICAL STERILITY TESTING COMPANIES

  • 11.1. Pharmaceutical Sterility Testing Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12 . COMPANY PROFILES OF PHARMACEUTICAL STERILITY TESTING INDUSTRY

  • 12.1. Company Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. Pacific Biolabs
    • 12.3.1. Company Overview
    • 12.3.2. Company Revenue
    • 12.3.3. Products
    • 12.3.4. Recent Developments
  • 12.4. Steris Plc
    • 12.4.1. Company Overview
    • 12.4.2. Company Revenue
    • 12.4.3. Products
    • 12.4.4. Recent Developments
  • 12.5. Boston Analytical
    • 12.5.1. Company Overview
    • 12.5.2. Company Revenue
    • 12.5.3. Products
    • 12.5.4. Recent Developments
  • 12.6. Nelson Laboratories LLC (Sotera Health)
    • 12.6.1. Company Overview
    • 12.6.2. Company Revenue
    • 12.6.3. Products
    • 12.6.4. Recent Developments
  • 12.7. Sartorius AG
    • 12.7.1. Company Overview
    • 12.7.2. Company Revenue
    • 12.7.3. Products
    • 12.7.4. Recent Developments
  • 12.8. SOLVIAS AG
    • 12.8.1. Company Overview
    • 12.8.2. Company Revenue
    • 12.8.3. Products
    • 12.8.4. Recent Developments
  • 12.9. SGS SA
    • 12.9.1. Company Overview
    • 12.9.2. Company Revenue
    • 12.9.3. Products
    • 12.9.4. Recent Developments
  • 12.10. Labcorp
    • 12.10.1. Company Overview
    • 12.10.2. Company Revenue
    • 12.10.3. Products
    • 12.10.4. Recent Developments
  • 12.11. Pace Analytical
    • 12.11.1. Company Overview
    • 12.11.2. Company Revenue
    • 12.11.3. Products
    • 12.11.4. Recent Developments
  • 12.12. Charles River Laboratories
    • 12.12.1. Company Overview
    • 12.12.2. Company Revenue
    • 12.12.3. Products
    • 12.12.4. Recent Developments
  • 12.13. Thermo Fisher Scientific Inc.
    • 12.13.1. Company Overview
    • 12.13.2. Company Revenue
    • 12.13.3. Products
    • 12.13.4. Recent Developments
  • 12.14. Rapid Micro Biosystems
    • 12.14.1. Company Overview
    • 12.14.2. Company Revenue
    • 12.14.3. Products
    • 12.14.4. Recent Developments
  • 12.15. Almac Group
    • 12.15.1. Company Overview
    • 12.15.2. Company Revenue
    • 12.15.3. Products
    • 12.15.4. Recent Developments
  • 12.16. Labor LS SE & Co KG
    • 12.16.1. Company Overview
    • 12.16.2. Company Revenue
    • 12.16.3. Products
    • 12.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies